BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25855505)

  • 1. Synthesis of 5,6-dihydro-4H-benzo[d]isoxazol-7-one and 5,6-dihydro-4H-isoxazolo[5,4-c]pyridin-7-one derivatives as potential Hsp90 inhibitors.
    Musso L; Cincinelli R; Giannini G; Manetti F; Dallavalle S
    Chem Biol Drug Des; 2015 Nov; 86(5):1030-5. PubMed ID: 25855505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 3,5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitors.
    Sun J; Lin C; Qin X; Dong X; Tu Z; Tang F; Chen C; Zhang J
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3129-34. PubMed ID: 26112442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.
    Baruchello R; Simoni D; Marchetti P; Rondanin R; Mangiola S; Costantini C; Meli M; Giannini G; Vesci L; Carollo V; Brunetti T; Battistuzzi G; Tolomeo M; Cabri W
    Eur J Med Chem; 2014 Apr; 76():53-60. PubMed ID: 24565573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.
    Vallée F; Carrez C; Pilorge F; Dupuy A; Parent A; Bertin L; Thompson F; Ferrari P; Fassy F; Lamberton A; Thomas A; Arrebola R; Guerif S; Rohaut A; Certal V; Ruxer JM; Gouyon T; Delorme C; Jouanen A; Dumas J; Grépin C; Combeau C; Goulaouic H; Dereu N; Mikol V; Mailliet P; Minoux H
    J Med Chem; 2011 Oct; 54(20):7206-19. PubMed ID: 21972823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
    Jeong JH; Oh YJ; Lho Y; Park SY; Liu KH; Ha E; Seo YH
    Eur J Med Chem; 2016 Nov; 124():1069-1080. PubMed ID: 27783977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.
    Bargiotti A; Musso L; Dallavalle S; Merlini L; Gallo G; Ciacci A; Giannini G; Cabri W; Penco S; Vesci L; Castorina M; Milazzo FM; Cervoni ML; Barbarino M; Pisano C; Giommarelli C; Zuco V; De Cesare M; Zunino F
    Eur J Med Chem; 2012 Jul; 53():64-75. PubMed ID: 22538015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
    J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and pharmacological evaluation of 4,5-diarylisoxazols bearing amino acid residues within the 3-amido motif as potent heat shock protein 90 (Hsp90) inhibitors.
    Zhang C; Wang X; Liu H; Zhang M; Geng M; Sun L; Shen A; Zhang A
    Eur J Med Chem; 2017 Jan; 125():315-326. PubMed ID: 27688186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient regioselective synthesis and potential antitumor evaluation of isoxazolo[5,4-b]pyridines and related annulated compounds.
    Hamama WS; Ibrahim ME; Zoorob HH
    Arch Pharm (Weinheim); 2012 Jun; 345(6):468-75. PubMed ID: 22383332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors.
    Chen D; Shen A; Li J; Shi F; Chen W; Ren J; Liu H; Xu Y; Wang X; Yang X; Sun Y; Yang M; He J; Wang Y; Zhang L; Huang M; Geng M; Xiong B; Shen J
    Eur J Med Chem; 2014 Nov; 87():765-81. PubMed ID: 25313505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the In-silico Design of New HSP90 Inhibitors: Molecular Docking and 3D-QSAR CoMFA Studies of Tetrahydropyrido [4, 3-d] Pyrimidine Derivatives as HSP90 Inhibitors.
    Sepehri B; Ghavami R
    Med Chem; 2018; 14(5):439-450. PubMed ID: 29564982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF NEW SULFONAMIDE ISOXAZOLO[5,4-b]PYRIDINE DERIVATIVES.
    Poręba K; Pawlik K; Rembacz KP; Kurowska E; Matuszyk J; Długosz A
    Acta Pol Pharm; 2015; 72(4):727-35. PubMed ID: 26647630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90.
    Shin SC; El-Damasy AK; Lee JH; Seo SH; Kim JH; Seo YH; Lee Y; Yu JH; Bang EK; Kim EE; Keum G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33317068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.
    Taddei M; Ferrini S; Giannotti L; Corsi M; Manetti F; Giannini G; Vesci L; Milazzo FM; Alloatti D; Guglielmi MB; Castorina M; Cervoni ML; Barbarino M; Foderà R; Carollo V; Pisano C; Armaroli S; Cabri W
    J Med Chem; 2014 Mar; 57(6):2258-74. PubMed ID: 24588105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases.
    Fogliatto G; Gianellini L; Brasca MG; Casale E; Ballinari D; Ciomei M; Degrassi A; De Ponti A; Germani M; Guanci M; Paolucci M; Polucci P; Russo M; Sola F; Valsasina B; Visco C; Zuccotto F; Donati D; Felder E; Pesenti E; Galvani A; Mantegani S; Isacchi A
    Clin Cancer Res; 2013 Jul; 19(13):3520-32. PubMed ID: 23674492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of 3,5,6,7-tetrasubstituted isoxazolo[4,5-b]pyridines and an evaluation of their in vitro antiproliferative activity.
    Poreba K; Wietrzyk J
    Adv Clin Exp Med; 2012; 21(5):563-71. PubMed ID: 23356192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of a new class of heat shock protein 90 inhibitors, designed by energy-based pharmacophore virtual screening.
    Lauria A; Abbate I; Gentile C; Angileri F; Martorana A; Almerico AM
    J Med Chem; 2013 Apr; 56(8):3424-8. PubMed ID: 23520985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principal component analysis on molecular descriptors as an alternative point of view in the search of new Hsp90 inhibitors.
    Lauria A; Ippolito M; Almerico AM
    Comput Biol Chem; 2009 Oct; 33(5):386-90. PubMed ID: 19660987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90.
    Baruchello R; Simoni D; Grisolia G; Barbato G; Marchetti P; Rondanin R; Mangiola S; Giannini G; Brunetti T; Alloatti D; Gallo G; Ciacci A; Vesci L; Castorina M; Milazzo FM; Cervoni ML; Guglielmi MB; Barbarino M; Foderà R; Pisano C; Cabri W
    J Med Chem; 2011 Dec; 54(24):8592-604. PubMed ID: 22066525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.